In the Journals

Melanoma treatment at high-volume centers improves long-term survival

April 12, 2019
Treatment for primary nonmetastatic melanoma at high-volume facilities is associated with improved long-term patient survival, with academic centers…

In the Journals

Suture spacing yields similar cosmetic outcomes during linear wound closures

April 9, 2019
Researchers reported no statistically significant difference in wound cosmesis or total complications between running cutaneous sutures spaced 2 mm…

Meeting News

Corticosteroid use for immune-mediated adverse events often does not match guidelines

April 4, 2019
FORT WORTH, Texas — An evaluation of physician prescribing practices showed utilization of corticosteroids for management of immune-mediated…

Meeting News

Genetic testing can detect melanoma earlier, but tailored approach is required

March 21, 2019
Genetic testing can help increase early detection of melanoma among patients and their family members, according to a presenter at HemOnc Today New…

Meeting News

Standards evolve for adjuvant therapy of melanoma

March 21, 2019
NEW YORK — A strong rationale exists for offering adjuvant therapy to certain patients with melanoma, but several aspects of treatment remain…

NCI scientist to receive Szent-Györgyi Prize for Progress in Cancer Research

March 14, 2019
Steven A. Rosenberg, MD, PhD, will receive the 2019 Szent-Györgyi Prize for Progress in Cancer Research. The annual prize, awarded by National…


Proposed FDA sunscreen rule could save lives, reduce confusion

March 12, 2019
The FDA has proposed a rule that it says would update regulatory requirements for most sunscreen products sold in the United States. These…

Meeting News

HemOnc Today New York uses ‘practical, interactive approach’ to help providers improve cancer care

March 6, 2019
HemOnc Today is pleased to announce plans for a 3-day CME meeting designed to offer expert perspectives on advances in cancer treatment. …

FDA News

FDA approves Keytruda for adjuvant treatment of melanoma

February 19, 2019
The FDA approved pembrolizumab for adjuvant treatment of patients who have melanoma with lymph node involvement who underwent complete resection…

John Wayne Cancer Institute appoints executive director

February 13, 2019
Steven O’Day, MD, has been named executive director of John Wayne Cancer Institute and Cancer Clinic at Providence St. John’s Health…


American Academy of Dermatology updates guidelines for primary cutaneous melanoma

January 11, 2019
The American Academy of Dermatology released new guidelines on melanoma treatment. The guidelines address areas such as melanoma in pregnancy and…

Roswell Park immunotherapy expert honored for melanoma research

January 11, 2019
Igor Puzanov, MD, MSCI, FACP, received the Melanoma Foundation Award for outstanding and lifelong

FDA News

FDA approves Vitrakvi for solid tumors with NTRK gene fusion

November 27, 2018
The FDA granted accelerated approval to larotrectinib for the treatment of adults and children with solid tumors that have a neurotrophic receptor…

Meeting News

Triple combination appears safe, effective for advanced BRAF V600-mutant melanoma

November 8, 2018
NEW YORK — The addition of spartalizumab to dabrafenib and trametinib appeared safe and effective for previously untreated patients with…


Melanoma surveillance could benefit patients with chronic lymphocytic leukemia

November 5, 2018
Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma could benefit from active melanoma surveillance, according to study results…

In the Journals

Dabrafenib-trametinib combination shows durable RFS benefit in BRAF V600-mutant melanoma

November 2, 2018
Adjuvant treatment with dabrafenib plus trametinib demonstrated a durable RFS benefit compared with placebo for patients with resected stage III BRAF…

In the Journals

Frequently eating organic food may lower cancer risk

October 22, 2018
Researchers observed a significant reduction in overall risk of cancer among individuals who consumed organic food at a high frequency, according to…


Tinder-style app helps medical students identify melanoma

October 17, 2018
A smartphone app may help medical students more accurately differentiate melanomas from benign skin lesions, according to study results published in…


Patient age influences response to immunotherapy for melanoma

October 5, 2018
Age should be a consideration when predicting response to immunotherapy for melanoma, according to study results published in Clinical Cancer

FDA News

FDA approves Libtayo, first drug specifically for advanced cutaneous squamous cell carcinoma

September 28, 2018
The FDA approved cemiplimab-rwlc for IV treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced cutaneous…

Healio Jobs